Quick Answer
Decoy Therapeutics Inc. reported Total Assets of $11.06 million for fiscal year 2025.
Decoy Therapeutics Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $11.06M | +265.8% |
| 2024 | $3.02M | -54.1% |
| 2023 | $6.59M | -55.0% |
| 2022 | $14.65M | -64.1% |
| 2021 | $40.83M | +63.8% |
| 2020 | $24.93M | +79.4% |
| 2019 | $13.89M | +110.1% |
| 2018 | $6.61M | -81.1% |
| 2017 | $34.99M | -44.6% |
| 2016 | $63.21M | -33.5% |
| 2015 | $95.07M | +167.0% |
| 2014 | $35.61M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $6.10M | +58.0% | +337.8% |
| June 30, 2025 | $1.39M | -60.8% | -40.5% |
| March 31, 2025 | $2.34M | -52.1% | -22.6% |
| December 31, 2024 | $3.02M | -54.1% | -21.7% |
| September 30, 2024 | $3.86M | -54.1% | +8.6% |
| June 30, 2024 | $3.55M | -70.5% | -27.2% |
| March 31, 2024 | $4.88M | -51.4% | -25.9% |
| December 31, 2023 | $6.59M | -55.0% | -21.6% |
- Decoy Therapeutics Inc. showed an increase of +265.8% in Total Assets compared to the prior fiscal year.
- Over the 2014–2025 period, Decoy Therapeutics Inc.’s total assets has declined by 69.0% (from $35.61 million to $11.06 million).
- The most recent figure is from Decoy Therapeutics Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: